Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Covid-19: Course and prognosis in patients with severe clinical form

Breadcrumb

  • Home
  • Covid-19: Course and prognosis in patients with severe clinical form

Liliya Grahlyova 1, * and Aneliya Gotseva 2

1 Laboratory of Cytogenetics and Molecular Biology, Military Medical Academy, Sofia, Bulgaria, 1606 3 Geogri Sofiiski str.  
2 Laboratory of Virology, Military Medical Academy, Sofia, Bulgaria.

Review Article
 
World Journal of Biology Pharmacy and Health Sciences, 2023, 16(03), 001–006.
Article DOI: 10.30574/wjbphs.2023.16.3.0492
DOI url: https://doi.org/10.30574/wjbphs.2023.16.3.0492

Received on 22 October 2023; revised on 28 November 2023; accepted on 01 December 2023

Our aim is to identify factors of unfavorable prognostic significance in hospitalized patients with severe COVID-19, an analysis of clinical and demographic characteristics and routine laboratory tests was performed.  For the following period: March - July 2023, 25 patients with severe COVID-19 needing intensive care and treatment were hospitalized in Military Medical Academy Sofia (Bulgaria). The diagnosis has been confirmed by RT-PCR analysis for SARS-CoV-2 detection. According to the prognosis, the target group of patients were divided into two groups - discharger and deceased. The average age of the analyzed cohort was 77.6 years. The most commonly reported clinical symptoms include fever, cough, shortness of breath, and neurological symptoms. We found that all patients with severe COVID-19 were comorbid and elderly. The average hospital stay in intensive care is 11.9 days. Nearly half of the cases had fatal outcome (12/25). Among the factors associated with the clinical severity of COVID-19 and mortality are advanced age, presence of chronic concomitant diseases, development of pneumonia and/or neurological complications, as well as deviations in some laboratory parameters.

Severe COVID-19; Demographic Factors; Сomorbid Conditions; Prognosis

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2023-0492.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Liliya Grahlyova and Aneliya Gotseva. Covid-19: Course and prognosis in patients with severe clinical form. World Journal of Biology Pharmacy and Health Sciences, 2023, 16(03), 001–006. Article DOI: https://doi.org/10.30574/wjbphs.2023.16.3.0492

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution